1 2870 143 YOGA-BASED PULMONARY REHABILITATION FOR THE MANAGEMENT OF DYSPNEA IN COAL MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: COAL MINE DUST EXPOSURE CAUSES CHRONIC AIRFLOW LIMITATION IN COAL MINERS RESULTING IN DYSPNEA, FATIGUE, AND EVENTUALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). YOGA CAN ALLEVIATE DYSPNEA IN COPD BY IMPROVING VENTILATORY MECHANICS, REDUCING CENTRAL NEURAL DRIVE, AND PARTIALLY RESTORING NEUROMECHANICAL COUPLING OF THE RESPIRATORY SYSTEM. OBJECTIVES: TO EVALUATE THE EFFECTIVENESS OF INTEGRATED APPROACH OF YOGA THERAPY (IAYT) IN THE MANAGEMENT OF DYSPNEA AND FATIGUE IN COAL MINERS WITH COPD. MATERIALS AND METHODS: RANDOMIZED, WAITLIST CONTROLLED, SINGLE-BLIND CLINICAL TRIAL. EIGHTY-ONE COAL MINERS (36-60 YEARS) WITH STABLE STAGES II AND III COPD WERE RECRUITED. THE YOGA GROUP RECEIVED AN IAYT MODULE FOR COPD THAT INCLUDED ASANAS, LOOSENING EXERCISES, BREATHING PRACTICES, PRANAYAMA, CYCLIC MEDITATION, YOGIC COUNSELING AND LECTURES 90 MIN/DAY, 6 DAYS/WEEK FOR 12 WEEKS. MEASUREMENTS OF DYSPNEA AND FATIGUE ON THE BORG SCALE, EXERCISE CAPACITY BY THE 6 MIN WALK TEST, PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2%), AND PULSE RATE (PR) USING PULSE OXIMETRY WERE MADE BEFORE AND AFTER THE INTERVENTION. RESULTS: STATISTICALLY SIGNIFICANT WITHIN GROUP REDUCTIONS IN DYSPNEA (P < 0.001), FATIGUE (P < 0.001) SCORES, PR (P < 0.001), AND SIGNIFICANT IMPROVEMENTS IN SPO2% (P < 0.001) AND 6 MIN WALK DISTANCE (P < 0.001) WERE OBSERVED IN THE YOGA GROUP; ALL EXCEPT THE LAST WERE SIGNIFICANT COMPARED TO CONTROLS (P < 0.001). CONCLUSIONS: FINDINGS INDICATE THAT IAYT BENEFITS COAL MINERS WITH COPD, REDUCING DYSPNEA; FATIGUE AND PR, AND IMPROVING FUNCTIONAL PERFORMANCE AND PERIPHERAL CAPILLARY SPO2%. YOGA CAN NOW BE INCLUDED AS AN ADJUNCT TO CONVENTIONAL THERAPY FOR PULMONARY REHABILITATION PROGRAMS FOR COPD PATIENTS. 2016 2 2787 52 YOGA THERAPY DECREASES DYSPNEA-RELATED DISTRESS AND IMPROVES FUNCTIONAL PERFORMANCE IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A PILOT STUDY. BACKGROUND: THERE HAS BEEN LIMITED STUDY OF YOGA TRAINING AS A COMPLEMENTARY EXERCISE STRATEGY TO MANAGE THE SYMPTOM OF DYSPNEA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). PURPOSE: THE PRIMARY PURPOSE OF THIS PILOT STUDY WAS TO EVALUATE A YOGA PROGRAM FOR ITS SAFETY, FEASIBILITY, AND EFFICACY FOR DECREASING DYSPNEA INTENSITY (DI) AND DYSPNEA-RELATED DISTRESS (DD) IN OLDER ADULTS WITH COPD. METHODS: CLINICALLY STABLE PATIENTS WITH COPD (N = 29; AGE 69.9 +/- 9.5; FORCED EXPIRATORY VOLUME IN 1 SECOND (FEV(1)) 47.7 +/- 15.6% PREDICTED; FEMALE = 21) WERE RANDOMIZED TO A 12-WEEK YOGA PROGRAM SPECIFICALLY DESIGNED FOR PEOPLE WITH COPD OR USUAL-CARE CONTROL (UC). THE TWICE-WEEKLY YOGA PROGRAM INCLUDED ASANAS (YOGA POSTURES) AND VISAMA VRITTI PRANAYAMA (TIMED BREATHING). SAFETY MEASURE OUTCOMES INCLUDED HEART RATE, OXYGEN SATURATION, DYSPNEA, AND PAIN. FEASIBILITY WAS MEASURED BY PATIENT-REPORTED ENJOYMENT, DIFFICULTY, AND ADHERENCE TO YOGA SESSIONS. AT BASELINE AND AT 12 WEEKS, DI AND DD WERE MEASURED DURING INCREMENTAL CYCLE ERGOMETRY AND A 6-MINUTE WALK (6MW) TEST. SECONDARY EFFICACY OUTCOMES INCLUDED PHYSICAL PERFORMANCE, PSYCHOLOGIC WELL-BEING, AND HEALTH-RELATED QUALITY OF LIFE (HRQOL). RESULTS: YOGA TRAINING WAS SAFE AND FEASIBLE FOR PATIENTS WITH COPD. WHILE YOGA TRAINING HAD ONLY SMALL EFFECTS ON DI AFTER THE 6MW TEST (EFFECT SIZE [ES], 0.20; P = 0.60), THERE WERE GREATER REDUCTIONS IN DD IN THE YOGA GROUP COMPARED TO UC (ES, 0.67; P = 0.08). YOGA TRAINING ALSO IMPROVED 6MW DISTANCE (+71.7 +/- 21.8 FEET VERSUS -27.6 +/- 36.2 FEET; ES = 0.78, P = 0.04) AND SELF-REPORTED FUNCTIONAL PERFORMANCE (ES = 0.79, P = 0.04) COMPARED TO UC. THERE WERE SMALL POSITIVE CHANGES IN MUSCLE STRENGTH AND HRQOL. CONCLUSIONS: ELDERLY PATIENTS WITH COPD PARTICIPATED SAFELY IN A 12-WEEK YOGA PROGRAM ESPECIALLY DESIGNED FOR PATIENTS WITH THIS CHRONIC ILLNESS. AFTER THE PROGRAM, THE SUBJECTS TOLERATED MORE ACTIVITY WITH LESS DD AND IMPROVED THEIR FUNCTIONAL PERFORMANCE. THESE FINDINGS NEED TO BE CONFIRMED IN A LARGER, MORE SUFFICIENTLY POWERED EFFICACY STUDY. 2009 3 2446 38 YOGA AND TAI CHI: A MIND-BODY APPROACH IN MANAGING RESPIRATORY SYMPTOMS IN OBSTRUCTIVE LUNG DISEASES. PURPOSE OF REVIEW: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS CHARACTERIZED BY AIRFLOW LIMITATION BECAUSE OF AIRWAY AND/OR ALVEOLAR ABNORMALITIES. SYMPTOMS INCLUDE DYSPNEA, COUGH, CHRONIC SPUTUM PRODUCTION. AS THE THIRD-RANKED CAUSE OF DEATH AS WELL AS DISABILITY-ADJUSTED LIFE YEARS (DALYS), IT POSES A SIGNIFICANT BURDEN ON PATIENTS, FAMILIES, HEALTHCARE SYSTEM AND SOCIETY. REGULAR PHYSICAL ACTIVITY IS LINKED TO DECREASE IN MORBIDITY AND MORTALITY ASSOCIATED WITH COPD, BUT IMPLEMENTATION REMAINS CHALLENGING. THERE IS A NEED FOR COMMUNITY-BASED INTERVENTIONS THAT PROMOTE PHYSICAL ACTIVITY. YOGA AND TAI CHI ARE WIDELY AVAILABLE IN THE COMMUNITY AND HAVE BEEN SHOWN TO BE BENEFICIAL IN PATIENTS WITH COPD AS WELL AS MANY OF THE CO-MORBID CONDITIONS ASSOCIATED WITH COPD. RECENT FINDINGS: YOGA AND TAI CHI HAVE BEEN FOUND TO BE MORE EFFECTIVE THAN USUAL CARE IN COPD WITH CLINICALLY MEANINGFUL IMPROVEMENTS IN 6-MIN WALK DISTANCE (6MWD), FORCED EXPIRATORY VOLUME IN 1 S (FEV1), AND HEALTH-RELATED QUALITY OF LIFE (HRQOL). THEY HAVE ALSO BEEN FOUND TO BE COMPARABLE TO PULMONARY REHABILITATION INTERVENTIONS. SUMMARY: YOGA AND TAI CHI PROVIDE COMMUNITY-BASED OPTIONS FOR PATIENTS WITH COPD TO IMPROVE THEIR PHYSICAL ACTIVITY, QUALITY OF LIFE, AND PULMONARY FUNCTION. 2020 4 2232 37 THE IMPACT OF YOGA ON INSPIRATORY MUSCLE PERFORMANCE IN VETERANS WITH COPD: A PILOT STUDY. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) CAUSES RESPIRATORY MUSCLE WEAKNESS THAT LEADS TO DISABLING DYSPNEA AND POOR FUNCTIONAL PERFORMANCE. THERAPIES ARE OFTEN GEARED TO IMPROVE INSPIRATORY MUSCLE PERFORMANCE. YOGA HAS BEEN SHOWN TO IMPROVE EXERCISE CAPACITY, QUALITY OF LIFE, AND SOME PULMONARY FUNCTION MEASURES IN COPD, BUT LITTLE RESEARCH HAS EXAMINED THE EFFECTS OF YOGA TRAINING ON INSPIRATORY MUSCLE PERFORMANCE. THE PURPOSE OF THIS STUDY WAS TO INVESTIGATE THE EFFECTS OF YOGA TRAINING ON INSPIRATORY MUSCLE PERFORMANCE IN MILITARY VETERANS USING THE TEST OF INCREMENTAL RESPIRATORY ENDURANCE (TIRE). A PROSPECTIVE PILOT STUDY EXAMINED A 6-WEEK YOGA TRAINING PROGRAM CONSISTING OF ASANA (POSES) AND PRANAYAMA (CONTROLLED BREATHING). SUBJECTS HAD BASELINE INSPIRATORY MUSCLE WEAKNESS. THE TIRE MEASURED INSPIRATORY MUSCLE PERFORMANCE VIA THE PRO2 DEVICE, PROVIDING MAXIMAL INSPIRATORY PRESSURE, SUSTAINED MAXIMAL INSPIRATORY PRESSURE, AND INSPIRATORY DURATION. SECONDARY MEASURES INCLUDED 6-MINUTE WALK DISTANCE, ST. GEORGE RESPIRATORY QUESTIONNAIRE, HOSPITAL ANXIETY AND DEPRESSION SCALE, AND SPIROMETRY. MEAN AGE AND BMI OF SUBJECTS WERE 67 +/- 3.6 YEARS AND 20.7 +/- 3.3, RESPECTIVELY. THE MAJORITY OF SUBJECTS HAD SEVERE (28.7%) OR VERY SEVERE (57.1%) COPD. STATISTICALLY SIGNIFICANT IMPROVE M E N T S WERE SEEN IN MAXIMAL INSPIRATORY PRESSURE (39.0 +/- 14.1 CMH2O TO 56.4 +/- 20.6 CMH2O) AND SUSTAINED MAXIMAL INSPIRATORY PRESSURE (244.1 +/- 100.6 PTU TO 308.1 +/- 121.2 PTU). NO STATISTICALLY SIGNIFICANT IMPROVEMENTS WE RE OBSERVED IN 6-MINUTE WALK DISTANCE, ST. GEORGE RESPIRATORY QUESTIONNAIRE, HOSPITAL ANXIETY AND DEPRESSION SCALE, OR SPIROMETRY. YOGA TRAINING HAS THE POTENTIAL IN IMPROVE INSPIRATORY MUSCLE PERFORMANCE IN VETERANS WITH SEVERE TO VERY SEVERE COPD WHO PRESENT WITH INSPIRATORY MUSCLE WEAKNESS. THIS IS OF IMPORTANCE BECAUSE IMPROVING INSPIRA-TORY MUSCLE PERFORMANCE HAS BEEN SHOWN TO IMPROVE COPD OUTCOMES. 2021 5 2344 30 USING A STANDARDIZED VINIYOGA PROTOCOL FOR LUNG CANCER SURVIVORS: A PILOT STUDY EXAMINING EFFECTS ON BREATHING EASE. ALTHOUGH LUNG CANCER IS PERCEIVED AS A DIRE DIAGNOSIS, INCREASES IN THE 5-YEAR SURVIVAL RATE OF INDIVIDUALS WITH NON-SMALL CELL LUNG CANCER (NSCLC) HAVE BEEN REPORTED. SURVIVORS, HOWEVER, CONTINUE TO BE EXCESSIVELY BURDENED WITH SYMPTOMS SUCH AS RESPIRATORY DISTRESS WHICH INTERFERE WITH FUNCTIONING AND QUALITY OF LIFE. WHILE EXERCISE AND PHYSICAL ACTIVITY ARE STRONGLY RECOMMENDED, NSCLC SURVIVORS MAY BE RELUCTANT TO PARTICIPATE DUE TO ACTUAL OR ANTICIPATED SHORTNESS OF BREATH EXACERBATED WITH MOVEMENT.THIS QUASI-EXPERIMENTAL, INTERVENTION-ONLY PILOT STUDY AIMED TO DETERMINE THE EFFECTS OF AN 8-WEEK STANDARDIZED YOGA PROTOCOL FOR STAGE I-IIIA NSCLC SURVIVORS (N=9). THE PROTOCOL WAS DEVELOPED WITHIN THE VINIYOGA (HATHA) TRADITION WITH RESPIRATORY EXPERTS. BREATHING EASE, DYSPNEA, OXYGEN SATURATION, AND RESPIRATORY FUNCTION WERE EXPLORED IN RELATIONSHIP TO YOGA PRACTICE (45-MINUTE SESSIONS ONCE PER WEEK AND HOME PRACTICE) USING REPEATED-MEASURES ANALYSIS. NUMBER OF PARTICIPANTS REPORTING DYSPNEA RANGED FROM 25 TO 50% PRIOR TO PRACTICE WITH NO SIGNIFICANT INCREASE DURING SESSIONS, AND MODERATE DECREASES NOTED AT TIMES. OXYGEN SATURATION REMAINED HIGH AND VITAL SIGNS STABLE; FORCED EXPIRATORY VOLUME IN 1 SECOND (FEV1) VALUES INCREASED SIGNIFICANTLY OVER THE 14-WEEK STUDY PERIOD (P<0.0001). YOGA, WITH AN EMPHASIS ON POSTURES COORDINATED WITH BREATHING AND MEDITATION PRACTICES, OFFERS A POTENTIALLY FEASIBLE AND BENEFICIAL OPTION THAT REQUIRES FURTHER STUDY IN THIS POPULATION. 2013 6 792 42 EFFECT OF YOGA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. YOGA IS ADJUNCTIVELY UTILIZED OUTSIDE THE UNITED STATES IN THE TREATMENT OF A VARIETY OF DISEASES, INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BUT THERE ARE NO STUDIES ASSESSING ITS ADJUNCTIVE EFFICACY IN THE UNITED STATES. WE PROSPECTIVELY EVALUATED THE EFFECTS OF YOGA TRAINING ON THE QUALITY OF LIFE (QOL) AND THE PARAMETERS OF LUNG FUNCTION IN PATIENTS WITH COPD. THIRTY-THREE PATIENTS WITH DOCUMENTED COPD, PER GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE CRITERIA, WERE RECRUITED. ALL PATIENTS RECEIVED STANDARD COPD CARE. THE QOL WAS ASSESSED BY THE ST. GEORGE RESPIRATORY QUESTIONNAIRE. STANDARD SPIROMETRY AND MAXIMUM INSPIRATORY (MAXIMAL INSPIRATORY PRESSURE) AND EXPIRATORY PRESSURE (MAXIMAL EXPIRATORY PRESSURE) WERE MEASURED. PATIENTS WERE TAUGHT SELECTED YOGA EXERCISES INCLUDING BREATHING EXERCISES, MEDITATION, AND YOGA POSTURES FOR 1 HOUR, THRICE A WEEK FOR 6 WEEKS BY A CERTIFIED YOGA THERAPIST. THE QUALITY OF LIFE AND LUNG FUNCTION WERE AGAIN ASSESSED AT THE END OF 6 WEEKS. TWENTY-TWO PATIENTS COMPLETED THE STUDY. DIFFERENCES IN PREYOGA VERSUS POSTYOGA SCORES WERE EVALUATED USING PAIRED T-TESTS. STATISTICALLY SIGNIFICANT IMPROVEMENTS (P < 0.05) WERE OBSERVED FOR THE ST. GEORGE RESPIRATORY QUESTIONNAIRE [95% CONFIDENCE INTERVAL (CI) 43.13-58.47], VITAL CAPACITY (95% CI 2.53-7.65), MAXIMAL INSPIRATORY PRESSURE (95% CI 6.62-23.64), AND MAXIMAL EXPIRATORY PRESSURE (95% CI 1.63-13.81). YOGA WHEN PRACTICED BY PATIENTS WITH COPD RESULTS IN IMPROVEMENT IN THE QOL AND LUNG FUNCTION ON A SHORT-TERM BASIS. ADDITIONAL RESEARCH IS NEEDED TO CONFIRM THESE FINDINGS IN A RANDOMIZED CONTROLLED TRIAL AND IN THE LONGER TERM. 2012 7 786 50 EFFECT OF YOGA BREATHING (PRANAYAMA) ON EXERCISE TOLERANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED, CONTROLLED TRIAL. OBJECTIVE: PULMONARY REHABILITATION IMPROVES EXERCISE TOLERANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). HOWEVER, MANY PATIENTS DO NOT HAVE ACCESS TO PULMONARY REHABILITATION PROGRAMS. WE HYPOTHESIZED THAT AN ALTERNATIVE TO PULMONARY REHABILITATION TO IMPROVE EXERCISE TOLERANCE IS THE PRACTICE OF PRANAYAMA, OR YOGA BREATHING, WHICH COULD BE DONE INDEPENDENTLY AT HOME. WE ALSO SOUGHT TO DETERMINE WHETHER YOGA NONPROFESSIONALS COULD ADEQUATELY TEACH PRANAYAMA TO PATIENTS. DESIGN: PROOF-OF-CONCEPT, RANDOMIZED, DOUBLE-BLIND, CONTROLLED PILOT TRIAL. SETTINGS/LOCATION: TWO ACADEMIC PULMONARY PRACTICES. SUBJECTS: FORTY-THREE PATIENTS WITH SYMPTOMATIC, MODERATE-TO-SEVERE COPD. INTERVENTIONS: TWELVE WEEKS OF PRANAYAMA PLUS EDUCATION VERSUS EDUCATION ALONE. TWO YOGA PROFESSIONALS TRAINED THE RESEARCH COORDINATORS TO CONDUCT ALL PRANAYAMA TEACHING AND MONITORED THE QUALITY OF THE TEACHING AND THE PRACTICE OF PRANAYAMA BY STUDY PARTICIPANTS. OUTCOME MEASURES: THE PRIMARY OUTCOME WAS A CHANGE IN THE 6-MIN WALK DISTANCE (6MWD). SECONDARY OUTCOMES INCLUDED CHANGES IN LUNG FUNCTION, MARKERS OF OXIDATIVE STRESS AND SYSTEMIC INFLAMMATION, AND MEASURES OF DYSPNEA AND QUALITY OF LIFE. RESULTS: THE 6MWD INCREASED IN THE PRANAYAMA GROUP (LEAST SQUARE MEAN [95% CONFIDENCE INTERVAL] = 28 M [-5 TO 61]) AND DECREASED IN THE CONTROL GROUP (-15 M [-47 TO 16]), WITH A NEARLY SIGNIFICANT TREATMENT EFFECT (P = 0.06) IN FAVOR OF PRANAYAMA. PRANAYAMA ALSO RESULTED IN SMALL IMPROVEMENTS IN INSPIRATORY CAPACITY AND AIR TRAPPING. BOTH GROUPS HAD SIGNIFICANT IMPROVEMENTS IN VARIOUS MEASURES OF SYMPTOMS, BUT NO OVERALL DIFFERENCES IN RESPIRATORY SYSTEM IMPEDANCE OR MARKERS OF OXIDATIVE STRESS OR SYSTEMIC INFLAMMATION. CONCLUSION: THIS PILOT STUDY SUCCESSFULLY DEMONSTRATED THAT PRANAYAMA WAS ASSOCIATED WITH IMPROVED EXERCISE TOLERANCE IN PATIENTS WITH COPD. LAY PERSONNEL WERE ABLE TO ADEQUATELY TEACH PATIENTS TO PRACTICE PRANAYAMA. THESE RESULTS SUGGEST THAT PRANAYAMA MAY HAVE SIGNIFICANT CLINICAL BENEFITS FOR SYMPTOMATIC PATIENTS WITH COPD, A CONCEPT THAT NEEDS TO BE CONFIRMED IN FUTURE, LARGER CLINICAL TRIALS. 2017 8 1181 34 EVALUATION OF THE FEASIBILITY OF A HOME-BASED TELEYOGA INTERVENTION IN PARTICIPANTS WITH BOTH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND HEART FAILURE. OBJECTIVE: TEST THE FEASIBILITY AND CLINICAL OUTCOMES OF A HOME-BASED VIDEOCONFERENCING YOGA INTERVENTION IN PARTICIPANTS DIAGNOSED WITH BOTH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND HEART FAILURE (HF). BACKGROUND: YOGA HAS POTENTIAL BENEFIT FOR SYMPTOM RELIEF IN PARTICIPANTS WITH COPD AND WITH HF; HOWEVER, FUNCTIONAL IMPAIRMENT AND TRANSPORTATION ISSUES CAN HINDER ACCESS TO TYPICAL YOGA CLASSES. METHODS: A CONTROLLED, NONRANDOMIZED TRIAL WAS CONDUCTED OF AN 8-WEEK TELEYOGA INTERVENTION VERSUS AN EDUCATIONAL CONTROL (INFORMATION LEAFLETS MAILED TO PARTICIPANTS WITH ONE WEEKLY PHONE CALL). ONE-HOUR TELEYOGA CLASSES WERE IMPLEMENTED TWICE WEEKLY VIA MULTIPOINT VIDEOCONFERENCING, WHICH CONNECTED PARTICIPANTS TO LIVE CLASSES VIA AN INTERNET CONNECTION TO THEIR TELEVISIONS. RESULTS: FOURTEEN PARTICIPANTS WITH COPD AND HF TOOK PART IN THE PILOT STUDY (7 IN THE INTERVENTION GROUP AND 8 IN THE CONTROL). INTERVENTION PARTICIPANTS WERE ADHERENT TO CLASSES, ABLE TO SAFELY PARTICIPATE, AND FOUND THE CLASSES ENJOYABLE AFTER THE 8-WEEK PROGRAM. DYSPNEA AFTER EXERCISE IMPROVED IN THE INTERVENTION GROUP. CONCLUSIONS: DESPITE THEIR FRAILTY, PATIENTS DIAGNOSED WITH BOTH COPD AND HF WERE ABLE TO PERFORM YOGA SAFELY IN THE HOME SETTING. TELEYOGA WAS ACCEPTABLE AND ADHERENCE WAS GOOD; HOWEVER, TECHNICAL ISSUES WERE AN IMPORTANT HINDRANCE TO PARTICIPATION. 2017 9 2271 46 THE RISKS AND BENEFITS OF YOGA FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES: TO DETERMINE THE EFFECTIVENESS AND SAFETY OF YOGA INTERVENTIONS ON DISEASE SYMPTOMS, QUALITY OF LIFE AND FUNCTION IN PATIENTS DIAGNOSED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). DATA SOURCES: MEDLINE/PUBMED, SCOPUS, AND CENTRAL (COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS) WERE SEARCHED THROUGH 6 JUNE 2019. REVIEW METHODS: RANDOMIZED CONTROLLED TRIALS ASSESSING THE EFFECTS OF YOGA ON QUALITY OF LIFE, DYSPNEA, EXERCISE CAPACITY, AND PULMONARY FUNCTION (FEV1) IN PATIENTS WITH COPD WERE INCLUDED. SAFETY WAS DEFINED AS SECONDARY OUTCOME. MEAN DIFFERENCES (MD) AND STANDARDIZED MEAN DIFFERENCES (SMD) WITH 95% CONFIDENCE INTERVALS (CIS) WERE COMPUTED. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: ELEVEN RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 586 PATIENTS WERE INCLUDED. META-ANALYSIS REVEALED EVIDENCE FOR EFFECTS OF YOGA COMPARED TO NO TREATMENT ON QUALITY OF LIFE ON THE COPD ASSESSMENT TEST (MD = 3.81; 95% CI = 0.97 TO 6.65; P = 0.009, I(2) = 70%), EXERCISE CAPACITY ASSESSED BY THE 6-MINUTE WALK TEST (MD = 25.53 M; 95% CI = 12.16 M TO 38.90 M; P = 0.001, I(2) = 0%), AND PULMONARY FUNCTION ASSESSED BY FEV1 PREDICTED (MD = 3.95%; 95% CI = 2.74% TO 5.17%; P < 0.001, I(2) = 0%). ONLY THE EFFECTS ON EXERCISE CAPACITY AND PULMONARY FUNCTION WERE ROBUST AGAINST METHODOLOGICAL BIAS. EFFECTS WERE ONLY PRESENT IN BREATHING-FOCUSED YOGA INTERVENTIONS BUT NOT IN INTERVENTIONS INCLUDING YOGA POSTURES. ADVERSE EVENTS WERE REPORTED INFREQUENTLY. CONCLUSION: THIS META-ANALYSIS FOUND ROBUST EFFECTS OF YOGA ON EXERCISE CAPACITY AND PULMONARY FUNCTION IN PATIENTS WITH COPD. YOGA, SPECIFICALLY YOGA BREATHING TECHNIQUES, CAN BE AN EFFECTIVE ADJUNCT INTERVENTION FOR PATIENTS WITH COPD. YOGA'S SAFETY NEEDS TO BE ASSESSED IN MORE DEPTH IN FUTURE STUDIES. 2019 10 173 49 A RANDOMIZED CONTROLLED STUDY ON ASSESSMENT OF HEALTH STATUS, DEPRESSION, AND ANXIETY IN COAL MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOLLOWING YOGA TRAINING. CONTEXT: PSYCHOLOGICAL COMORBIDITIES ARE PREVALENT IN COAL MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND CONTRIBUTE TO THE SEVERITY OF THE DISEASE REDUCING THEIR HEALTH STATUS. YOGA HAS BEEN SHOWN TO ALLEVIATE DEPRESSION AND ANXIETY ASSOCIATED WITH OTHER CHRONIC DISEASES BUT IN COPD NOT BEEN FULLY INVESTIGATED. AIM: THIS STUDY AIMED TO EVALUATE THE ROLE OF YOGA ON HEALTH STATUS, DEPRESSION, AND ANXIETY IN COAL MINERS WITH COPD. MATERIALS AND METHODS: THIS WAS A RANDOMIZED TRIAL WITH TWO STUDY ARMS (YOGA AND CONTROL), WHICH ENROLLED 81 COAL MINERS, RANGING FROM 36 TO 60 YEARS WITH STAGE II AND III STABLE COPD. BOTH GROUPS WERE EITHER ON CONVENTIONAL TREATMENT OR COMBINATION OF CONVENTIONAL CARE WITH YOGA PROGRAM FOR 12 WEEKS. RESULTS: DATA WERE COLLECTED THROUGH STANDARDIZED QUESTIONNAIRES; COPD ASSESSMENT TEST, BECK DEPRESSION INVENTORY AND STATE AND TRAIT ANXIETY INVENTORY AT THE BEGINNING AND THE END OF THE INTERVENTION. THE YOGA GROUP SHOWED STATISTICALLY SIGNIFICANT (P < 0.001) IMPROVEMENTS ON ALL SCALES WITHIN THE GROUP, ALL SIGNIFICANTLY DIFFERENT (P < 0.001) FROM CHANGES OBSERVED IN THE CONTROLS. NO SIGNIFICANT PREPOST CHANGES WERE OBSERVED IN THE CONTROL GROUP (P > 0.05). CONCLUSION: YOGA PROGRAM LED TO GREATER IMPROVEMENT IN PHYSICAL AND MENTAL HEALTH STATUS THAN DID CONVENTIONAL CARE. YOGA SEEMS TO BE A SAFE, FEASIBLE, AND EFFECTIVE TREATMENT FOR PATIENTS WITH COPD. THERE IS A NEED TO CONDUCT MORE COMPREHENSIVE, HIGH-QUALITY, EVIDENCE-BASED STUDIES TO SHED LIGHT ON THE CURRENT UNDERSTANDING OF THE EFFICACY OF YOGA IN THESE CHRONIC CONDITIONS AND IDENTIFY UNANSWERED QUESTIONS. 2016 11 1141 31 EFFICACY OF YOGA, TAI CHI AND QI GONG ON THE MAIN SYMPTOMS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A SYSTEMATIC REVIEW. INTRODUCTION: THE AIM OF THIS SYSTEMATIC REVIEW WAS TO SUMMARIZE THE EFFECTS OF YOGA, QI GONG OR TAI CHI IN COPD PATIENTS. METHODS: STUDIES EVALUATING EFFECTS OF THE SELECTED COMPLEMENTARY THERAPIES ON LUNG FUNCTION, DYSPNEA, QUALITY OF LIFE OR FUNCTIONAL EXERCISE CAPACITY IN COPD PATIENTS WERE IDENTIFIED AND REVIEWED FROM THREE DATABASES. RESULTS: EIGHTEEN STUDIES WERE INCLUDED. SIX STUDIES EVALUATED THE EFFECTS OF YOGA AND THE OTHERS FOCUSED ON TAI CHI OR QI GONG SEPARATELY OR COMBINED. THE DURATION OF THE PROGRAMS RANGED FROM 6 WEEKS TO 6 MONTHS AND THE FREQUENCY FROM 2 TO 7 TIMES A WEEK. EACH SESSION REACHED 30 TO 90 MINUTES. BENEFITS WERE OBSERVED ON LUNG FUNCTION AND FUNCTIONAL EXERCISE CAPACITY BUT BENEFIT WAS CLEARLY STATED NEITHER ON QUALITY OF LIFE NOR ON DYSPNEA. CONCLUSION: THIS SYSTEMATIC REVIEW HIGHLIGHTS THE POTENTIAL OF THESE THERAPIES AS COMPLEMENTARY THERAPEUTIC APPROACH IN COPD PATIENTS. 2019 12 200 41 A RESPONDER ANALYSIS OF THE EFFECTS OF YOGA FOR INDIVIDUALS WITH COPD: WHO BENEFITS AND HOW? BACKGROUND: WE PREVIOUSLY REPORTED THAT A TWICE-WEEKLY, MODIFIED IYENGAR YOGA PROGRAM WAS A SAFE AND VIABLE SELF-MANAGEMENT STRATEGY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). 1 OBJECTIVE: THE PRIMARY PURPOSE OF THIS EXPLORATORY ANALYSIS WAS TO CLASSIFY YOGA PARTICIPANTS INTO 1 OF 3 RESPONDER CATEGORIES BY USING MINIMUM CLINICALLY IMPORTANT DIFFERENCE (MCID) CRITERIA FOR EACH OF 3 VARIABLES: 6-MINUTE WALK DISTANCE (6MW), DISTRESS RELATED TO DYSPNEA (SHORTNESS OF BREATH; DD), AND FUNCTIONAL PERFORMANCE (FPI). CHANGES IN HEALTH-RELATED QUALITY OF LIFE (HRQL) AND IN PSYCHOLOGICAL WELL-BEING (ANXIETY AND DEPRESSION), AND PARTICIPANTS' SELF-REPORTED IMPROVEMENTS BY RESPONDER CATEGORY WERE ALSO EXAMINED. A SECONDARY GOAL WAS TO IDENTIFY BASELINE PARTICIPANT CHARACTERISTICS, INCLUDING INITIAL RANDOMIZATION ASSIGNMENT THAT MIGHT PREDICT RESPONSE TO TREATMENT. METHODS: PARTICIPANTS WERE RANDOMLY ASSIGNED TO EITHER AN INITIAL YOGA (IY) OR AN ENHANCED WAIT-LIST CONTROL (WLC) GROUP. THOSE IN THE WLC GROUP WERE OFFERED THE YOGA PROGRAM IMMEDIATELY FOLLOWING THE IY GROUP'S PARTICIPATION. INDIVIDUALS FROM BOTH GROUPS WHO COMPLETED AT LEAST 18 OF 24 YOGA CLASSES WERE CATEGORIZED AS RESPONDERS, PARTIAL RESPONDERS, OR NON-RESPONDERS FOR EACH OF THE 3 OUTCOME VARIABLES (6MW, DD, FPI) ON THE BASIS OF MCID CRITERIA. BASELINE CHARACTERISTICS AND CHANGES IN HRQL AND PSYCHOLOGICAL WELL-BEING WERE ALSO ANALYZED. RESULTS: NONE OF THE PARTICIPANTS DEMONSTRATED MCIDS FOR ALL 3 OUTCOMES; HOWEVER, 6 WERE CLASSIFIED AS RESPONDERS FOR 2 OUT-COME VARIABLES AND 4 WERE CLASSIFIED AS NON-RESPONDERS FOR ALL 3 OUTCOME VARIABLES. TWO-THIRDS OF THE FEMALE PARTICIPANT GROUP AND ONE-THIRD OF THE MALE PARTICIPANT GROUP COMPLETED THE YOGA PROGRAM. DD RESPONDERS SHOWED INCREASED ANXIETY LEVELS, WHEREAS ANXIETY LEVELS OF THE DD NON-RESPONDERS REMAINED UNCHANGED. FPI RESPONDERS REPORTED SIGNIFICANT IMPROVEMENTS IN PHYSICAL FUNCTION, WHEREAS PARTIAL AND NON-FPI RESPONDERS NOTED DECLINED FUNCTION. PARTICIPANTS ASSIGNED TO THE IY GROUP DEMONSTRATED GREATER BENEFIT FROM YOGA THAN DID THOSE IN THE W LC GROUP. CONCLUSIONS: ALTHOUGH THIS MODIFIED IYENGAR YOGA PROGRAM APPEARS TO HAVE BENEFITED SOME INDIVIDUALS WITH COPD, FURTHER STUDIES ARE REQUIRED TO ASSESS WHO THE INTERVENTION WORKS FOR AND UNDER WHAT CONDITIONS. 2012 13 1139 34 EFFICACY OF YOGA TRAINING IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES: TO EVALUATE THE IMPACT OF YOGA TRAINING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). METHOD: A LITERATURE SEARCH WAS PERFORMED IN PUBMED, COCHRANE LIBRARY, EMBASE, CINAHL, AND WEB OF SCIENCE FOR RELEVANT STUDIES PUBLISHED BEFORE JUNE 2017. QUALITY ASSESSMENT, SENSITIVITY ANALYSIS AND HETEROGENEITY WERE PERFORMED. STATA12.0 SOFTWARE WAS USED FOR STATISTICAL ANALYSIS. RESULTS: TEN STUDIES WERE ELIGIBLE FOR THIS ANALYSIS. THERE WERE SIGNIFICANTLY GREATER IMPROVEMENTS IN 6MWD (P = 0.000), BORG SCALE SCORES (P = 0.018), FEV1 VALUE (P = 0. 013), PACO2 (P = 0.037), SGRQ SCORES (P = 0. 000) AND CAT SCORES (P = 0.009) IN YOGA TRAINING PATIENTS. NO STATISTICALLY SIGNIFICANT DIFFERENCE WAS OBSERVED IN THE FEV1/FVC (P = 0.75), FEV1 PREDICTED VALUE (P = 0.057) AND FVC (P = 0.05). CONCLUSIONS: THIS META-ANALYSIS INDICATES THAT YOGA TRAINING CAN BE AN ACCEPTABLE AND APPROPRIATED ADJUNCTIVE REHABILITATION PROGRAM FOR COPD PATIENTS. 2018 14 121 37 A PILOT STUDY OF THE FEASIBILITY AND OUTCOMES OF YOGA FOR LUNG CANCER SURVIVORS. PURPOSE/OBJECTIVES: TO DETERMINE THE FEASIBILITY OF A STANDARDIZED YOGA INTERVENTION FOR SURVIVORS OF NON-SMALL CELL LUNG CANCER (NSCLC) AND, EFFECTS ON SLEEP, MOOD, SALIVARY CORTISOL LEVELS, AND QUALITY OF LIFE (QOL). DESIGN: THIS 14-WEEK, ONE-GROUP, REPEATED-MEASURES STUDY INCLUDED A THREE-WEEK PREINTERVENTION PHASE, EIGHT WEEKS OF YOGA CLASSES (40 MINUTES ONCE PER WEEK) AND HOME PRACTICE, AND A THREE-WEEK POSTINTERVENTION PHASE. FOLLOW-UP OCCURRED AT THREE AND SIX MONTHS POSTSTUDY. SETTING: A COMMUNITY-BASED CANCER SUPPORT CENTER IN THE MIDWESTERN UNITED STATES. SAMPLE: 7 ADULTS WHO HAD COMPLETED INITIAL TREATMENT FOR STAGES I-IIIA NSCLC. METHODS: A STANDARDIZED YOGA PROTOCOL WAS DEVELOPED PRIOR TO THE STUDY BY EXPERTS IN THE FIELD. BREATHING EASE WAS MONITORED BEFORE, DURING, AND AFTER CLASSES TO ASSESS FEASIBILITY OF MOVEMENT WITHOUT COMPROMISING RESPIRATORY STATUS WHILE DOING YOGA. DATA ANALYSIS INCLUDED DESCRIPTIVE STATISTICS, REPEATED-MEASURES ANALYSIS OF VARIANCE, AND SALIVARY CORTISOL ANALYSIS. MAIN RESEARCH VARIABLES: SLEEP QUALITY, MOOD, SALIVARY CORTISOL, AND QOL WERE ASSESSED USING THE PITTSBURGH SLEEP QUALITY INDEX, PROFILE OF MOOD STATES-BRIEF, A CORTISOL MEASUREMENT, AND THE MEDICAL OUTCOMES SURVEY SF-36(R), RESPECTIVELY. BREATHING EASE WAS ASSESSED USING A DYSPNEA NUMERIC RATING SCALE AS WELL AS OBSERVATION OF PARTICIPANTS. FINDINGS: PARTICIPANTS WITH VARYING STAGES OF DISEASE AND LENGTH OF SURVIVORSHIP WERE ABLE TO PERFORM YOGA WITHOUT RESPIRATORY DISTRESS. CLASS ATTENDANCE EXCEEDED 95%, AND ALL PRACTICED AT HOME. MOOD, SLEEP EFFICIENCY, AND QOL SIGNIFICANTLY IMPROVED; SALIVARY CORTISOL LEVELS DECREASED OVER TIME. CONCLUSIONS: YOGA WAS FEASIBLE FOR NSCLC SURVIVORS WITHOUT FURTHER COMPROMISING BREATHING WITH MOVEMENT. POTENTIAL BENEFITS WERE IDENTIFIED, SUPPORTING THE NEED FOR FUTURE CLINICAL TRIALS WITH LARGER SAMPLES STRATIFIED BY CANCER STAGE, TREATMENT, AND LENGTH OF SURVIVORSHIP. IMPLICATIONS FOR NURSING: NURSES AND HEALTHCARE PROVIDERS SHOULD CONSIDER YOGA AS A MIND-BODY PRACTICE TO MANAGE STRESS, IMPROVE MOOD AND SLEEP, AND POTENTIALLY ENHANCE QOL FOR NSCLC SURVIVORS. 2014 15 1396 25 IMPACT OF YOGA IN A CASE OF VOCAL CORD DYSFUNCTION WITH DYSAUTONOMIA. A 23-YEAR-OLD FEMALE WITH A PAST MEDICAL HISTORY OF GASTROESOPHAGEAL REFLUX DISEASE PRESENTED WITH SHORTNESS OF BREATH INDUCED BY EXERCISE AND CERTAIN ODORS. SHE REPORTED THE SYMPTOMS OF AUTONOMIC DYSFUNCTION INCLUDING FATIGUE, CHEST PAIN, LIGHTHEADEDNESS, HEADACHES, NUMBNESS/TINGLING IN THE ARMS AND LEGS, AND EXERCISE INTOLERANCE. VITAL SIGNS WERE SIGNIFICANT FOR ORTHOSTATIC INTOLERANCE. VOLUME FLOW LOOP IN THE PULMONARY FUNCTION TESTS SHOWED A FLATTENING OF THE INSPIRATORY PORTION CHARACTERISTIC OF VOCAL CORD DYSFUNCTION. LARYNGOSCOPY SHOWED DYSKINESIA OF THE LEFT VOCAL CORD, ESPECIALLY AFTER EXERCISE. MULTIFACTORIAL APPROACH WAS USED INCLUDING INCREASED FLUID INTAKE AND BREATHING EXERCISES. AFTER 6 WEEKS OF BREATHING AND ISOMETRIC EXERCISES, THE PATIENT REPORTED IMPROVEMENT IN DYSPNEA AFTER EXERCISE. THIS CASE REPORT DEMONSTRATES THE THERAPEUTIC ROLE OF BREATHING AND ISOMETRIC EXERCISES IN THE MANAGEMENT OF VOCAL CORD AND AUTONOMIC DYSFUNCTION. 2017 16 2467 33 YOGA AS A THERAPY FOR ADOLESCENTS AND YOUNG ADULTS WITH CYSTIC FIBROSIS: A PILOT STUDY. RATIONALE: YOGA HAS BEEN SHOWN TO IMPROVE OUTCOMES IN PATIENTS WITH ASTHMA BUT HAS NOT BEEN INVESTIGATED IN CYSTIC FIBROSIS (CF) PATIENTS. METHODS: THIS WAS A PROSPECTIVE PILOT STUDY TO EVALUATE THE SAFETY OF A STANDARDIZED YOGA PROGRAM AMONG CF PATIENTS AGED 12 TO 25 YEARS. PARTICIPANTS ENGAGED IN A 50-MINUTE YOGA SESSION TWICE WEEKLY FOR 8 WEEKS CONDUCTED BY A CERTIFIED YOGA INSTRUCTOR USING A STANDARDIZED PROGRAM DESIGNED TO BE SAFE FOR HEALTH-COMPROMISED INDIVIDUALS. YOGA SESSIONS WERE INDIVIDUAL TO AVOID TRANSMISSION OF INFECTIONS. PRIMARY OUTCOME WAS SAFETY AND TOLERABILITY. SECONDARY OUTCOME MEASURES INCLUDED RESPIRATORY SYMPTOMS, THE CYSTIC FIBROSIS QUALITY OF LIFE INSTRUMENT (CFQ-R), LUNG FUNCTION, EASE OF BREATHING SCORE (MEASURE OF EXERCISE TOLERANCE), AND WEIGHT. RESULTS: ELEVEN PARTICIPANTS WERE ENROLLED, AND 10 COMPLETED THE STUDY. ADHERENCE WAS VERY GOOD; THE MEAN (SD) NUMBER OF SESSIONS COMPLETED WAS 14.2 (1.3) OUT OF 16 SESSIONS. EIGHT PATIENTS REPORTED 25 ADVERSE EVENTS. THE MOST COMMON WAS COUGH, REPORTED IN 7. TWO EVENTS WERE POSSIBLY RELATED TO STUDY PROCEDURES: CALF PAIN AND HEADACHE. THERE WERE NO SIGNIFICANT CHANGES IN DYSPNEA OR PAIN SCALES. THE MEAN (SD) CFQ-R RESPIRATORY DOMAIN SCORE INCREASED FROM SCREENING TO END OF STUDY: 67.9 (11.4) TO 82.1 (9.9), P=.04. THERE WERE NO SIGNIFICANT CHANGES IN THE OTHER OUTCOME MEASURES. CONCLUSIONS: IN THIS PILOT STUDY, A STANDARDIZED 8-WEEK YOGA PROGRAM WAS SAFE AND WELL TOLERATED AMONG ADOLESCENT AND YOUNG ADULT CF PATIENTS WITH MILD TO MODERATE LUNG DISEASE. THIS STUDY MAY BE HELPFUL TO YOGA INSTRUCTORS WHO ARE INTERESTED IN WORKING WITH CF PATIENTS. LARGER CONTROLLED TRIALS ARE WARRANTED TO DETERMINE FURTHER BENEFITS. 2015 17 1087 43 EFFECTS OF YOGA ON SYMPTOM MANAGEMENT IN BREAST CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY ON DISTRESSFUL SYMPTOMS IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY. MATERIALS AND METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO THEIR RADIOTHERAPY TREATMENT. INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60 MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY ONCE IN 10 DAYS DURING THE COURSE OF THEIR ADJUVANT RADIOTHERAPY. ASSESSMENTS INCLUDED ROTTERDAM SYMPTOM CHECK LIST AND EUROPEAN ORGANIZATION FOR RESEARCH IN THE TREATMENT OF CANCER-QUALITY OF LIFE (EORTC QOL C30) SYMPTOM SCALE. ASSESSMENTS WERE DONE AT BASELINE AND AFTER 6 WEEKS OF RADIOTHERAPY TREATMENT. RESULTS: A GLM REPEATED-MEASURES ANOVA SHOWED A SIGNIFICANT DECREASE IN PSYCHOLOGICAL DISTRESS (P = 0.01), FATIGUE (P = 0.007), INSOMNIA (P = 0.001), AND APPETITE LOSS (P = 0.002) OVER TIME IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS SIGNIFICANT IMPROVEMENT IN THE ACTIVITY LEVEL (P = 0.02) IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN PHYSICAL AND PSYCHOLOGICAL DISTRESS AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, APPETITE LOSS, AND CONSTIPATION. THERE WAS A SIGNIFICANT NEGATIVE CORRELATION BETWEEN THE ACTIVITY LEVEL AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, AND APPETITE LOSS. CONCLUSION: THE RESULTS SUGGEST BENEFICIAL EFFECTS WITH YOGA INTERVENTION IN MANAGING CANCER-AND TREATMENT-RELATED SYMPTOMS IN BREAST CANCER PATIENTS. 2009 18 572 19 DEFINITION OF A YOGA BREATHING (PRANAYAMA) PROTOCOL THAT IMPROVES LUNG FUNCTION. THIS STUDY TESTS THE HYPOTHESIS THAT YOGA BREATHING (PRANAYAMA) IMPROVES LUNG FUNCTION IN HEALTHY VOLUNTEERS DURING A 6-WEEK PROTOCOL. A RANDOMIZED CONTROLLED PILOT STUDY DEMONSTRATED AN IMPROVEMENT IN PEAK EXPIRATORY FLOW RATE AND FORCED EXPIRATORY VOLUME. THE EASY-TO-LEARN APPROACH CAN BE TRANSLATED TO THE INPATIENT AND OUTPATIENT SETTINGS. 2019 19 2173 31 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 20 1534 34 IYENGAR-YOGA COMPARED TO EXERCISE AS A THERAPEUTIC INTERVENTION DURING (NEO)ADJUVANT THERAPY IN WOMEN WITH STAGE I-III BREAST CANCER: HEALTH-RELATED QUALITY OF LIFE, MINDFULNESS, SPIRITUALITY, LIFE SATISFACTION, AND CANCER-RELATED FATIGUE. THIS STUDY AIMS TO TEST THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE, LIFE SATISFACTION, CANCER-RELATED FATIGUE, MINDFULNESS, AND SPIRITUALITY COMPARED TO CONVENTIONAL THERAPEUTIC EXERCISES DURING (NEO)ADJUVANT CYTOTOXIC AND ENDOCRINE THERAPY IN WOMEN WITH BREAST CANCER. IN A RANDOMIZED CONTROLLED TRIAL 92 WOMEN WITH BREAST CANCER UNDERGOING ONCOLOGICAL TREATMENT WERE RANDOMLY ENROLLED FOR A YOGA INTERVENTION (YI) (N = 45) OR FOR A PHYSICAL EXERCISE INTERVENTION (PEI) (N = 47). MEASUREMENTS WERE OBTAINED BEFORE (T 0) AND AFTER THE INTERVENTION (T 1) AS WELL AS 3 MONTHS AFTER FINISHING INTERVENTION (T 2) USING STANDARDIZED QUESTIONNAIRES. LIFE SATISFACTION AND FATIGUE IMPROVED UNDER PEI (P < 0.05) BUT NOT UNDER YI (T 0 TO T 2). REGARDING QUALITY OF LIFE (EORTC QLQ-C30) A DIRECT EFFECT (T 0 TO T 1; P < 0.001) OF YI WAS FOUND ON ROLE AND EMOTIONAL FUNCTIONING, WHILE UNDER PEI ONLY EMOTIONAL FUNCTIONING IMPROVED. SIGNIFICANT IMPROVEMENTS (P < 0.001) WERE OBSERVED AT BOTH T 1 AND T 2 ALSO FOR SYMPTOM SCALES IN BOTH GROUPS: DYSPNEA, APPETITE LOSS, CONSTIPATION, AND DIARRHEA. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THERAPIES FOR NONE OF THE ANALYZED VARIABLES NEITHER FOR T 1 NOR FOR T 2. DURING CHEMOTHERAPY, YOGA WAS NOT SEEN AS MORE HELPFUL THAN CONVENTIONAL THERAPEUTIC EXERCISES. THIS DOES NOT ARGUE AGAINST ITS USE IN THE RECOVERY PHASE. 2016